Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,123.24
(
0.84%
)
US TECH 100
26,112.20
(
1.32%
)
Dow Jones
49,511.97
(
0.13%
)
Brent Oil
97.02
(
2.12%
)
Bitcoin
79,375.62
(
3.99%
)
News Focus
News Focus
Post# of 130121
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

wadegarret

Send PM Follow Ignore
Followers 120
Posts 32312
Boards Moderated 2
Alias Born 10/04/2004

wadegarret

Member Level

Re: John Bates post# 65855

Wednesday, 11/06/2019 11:56:04 AM

Wednesday, November 06, 2019 11:56:04 AM

Post# of 130121
John- HZNP is a solid company

Just that the stock was $21 in Feb 2019 before the news of Teprotnamab thyroid drug potential. The stock went up 40% very quickly in Febuary, and has essentially been flat since. I don't see a catalyst that will push this over $30 till Teprotunamab gets approval, and some analysts give additional revenue estimates. That won't be till April or later. Till then, I see no catalyst.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today